Chromadex Historical Balance Sheet

CDXC Stock

USD 7.44 0.19 2.49%

Trend analysis of Chromadex Corp balance sheet accounts such as Short Long Term Debt Total of 1.7 M, Total Current Liabilities of 21.7 M or Total Stockholder Equity of 15.9 M provides information on Chromadex Corp's total assets, liabilities, and equity, which is the actual value of Chromadex Corp to its prevalent stockholders. By breaking down trends over time using Chromadex Corp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Chromadex Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chromadex Corp is a good buy for the upcoming year.

Chromadex Corp Inventory

7.36 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.

About Chromadex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Chromadex Corp at a specified time, usually calculated after every quarter, six months, or one year. Chromadex Corp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chromadex Corp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chromadex currently owns. An asset can also be divided into two categories, current and non-current.

Chromadex Corp Balance Sheet Chart

At present, Chromadex Corp's Cash is projected to increase significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 28.7 M, whereas Total Assets are forecasted to decline to about 28.4 M.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Capital Lease Obligations

Add Fundamental

Total Assets

Total assets refers to the total amount of Chromadex Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chromadex Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Chromadex Corp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Chromadex Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Capital Lease Obligations

Chromadex Corp capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Chromadex Corp asset purchases. For example, Chromadex Corp can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Chromadex Corp control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Most accounts from Chromadex Corp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Chromadex Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.At present, Chromadex Corp's Cash is projected to increase significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 28.7 M, whereas Total Assets are forecasted to decline to about 28.4 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	4.7M	4.3M	3.3M	1.7M
Total Assets	57.8M	54.1M	55.0M	28.4M

Short Long Term Debt Total Total Assets

Chromadex Corp balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Other Current Liab	Property Plant And Equipment Net	Current Deferred Revenue	Other Current Assets
Total Assets		0.39	0.75	0.94	-0.88	-0.75	0.77	0.9	0.89	0.87	0.9	0.78	-0.03	0.87	0.62	0.8	0.81	0.74	0.65	0.93	0.72	-0.08	0.74	0.83	-0.16	0.66
Short Long Term Debt Total	0.39		0.49	0.16	-0.08	-0.51	0.54	0.2	0.38	0.08	0.2	0.4	0.46	0.51	0.78	0.62	0.46	0.6	0.41	0.35	-0.09	0.42	0.32	0.53	-0.29	0.57
Total Current Liabilities	0.75	0.49		0.54	-0.6	-0.96	0.87	0.67	0.76	0.56	0.67	0.62	0.08	0.87	0.84	0.87	0.96	0.99	0.92	0.84	0.44	0.03	0.94	0.81	-0.19	0.8
Total Stockholder Equity	0.94	0.16	0.54		-0.95	-0.54	0.53	0.94	0.76	0.89	0.94	0.7	-0.12	0.67	0.36	0.55	0.64	0.51	0.49	0.89	0.78	-0.16	0.6	0.64	-0.06	0.48
Net Debt	-0.88	-0.08	-0.6	-0.95		0.58	-0.48	-0.99	-0.7	-0.87	-0.99	-0.55	0.15	-0.61	-0.37	-0.48	-0.69	-0.55	-0.58	-0.92	-0.81	0.19	-0.7	-0.57	0.09	-0.49
Retained Earnings	-0.75	-0.51	-0.96	-0.54	0.58		-0.82	-0.66	-0.79	-0.53	-0.66	-0.62	-0.09	-0.88	-0.89	-0.87	-0.99	-0.98	-0.93	-0.83	-0.35	-0.04	-0.94	-0.85	0.24	-0.89
Accounts Payable	0.77	0.54	0.87	0.53	-0.48	-0.82		0.53	0.82	0.61	0.53	0.64	0.09	0.93	0.75	0.95	0.79	0.87	0.67	0.69	0.49	0.04	0.71	0.87	-0.21	0.65
Cash	0.9	0.2	0.67	0.94	-0.99	-0.66	0.53		0.72	0.84	1.0	0.58	-0.09	0.65	0.48	0.54	0.76	0.64	0.66	0.96	0.76	-0.12	0.76	0.62	-0.12	0.57
Non Current Assets Total	0.89	0.38	0.76	0.76	-0.7	-0.79	0.82	0.72		0.83	0.72	0.7	-0.15	0.85	0.71	0.82	0.81	0.78	0.65	0.81	0.67	-0.18	0.71	0.95	-0.16	0.73
Non Currrent Assets Other	0.87	0.08	0.56	0.89	-0.87	-0.53	0.61	0.84	0.83		0.84	0.59	-0.29	0.64	0.39	0.58	0.61	0.53	0.43	0.8	0.9	-0.31	0.57	0.7	-0.11	0.4
Cash And Short Term Investments	0.9	0.2	0.67	0.94	-0.99	-0.66	0.53	1.0	0.72	0.84		0.58	-0.09	0.65	0.48	0.54	0.76	0.64	0.66	0.96	0.76	-0.12	0.76	0.62	-0.12	0.57
Net Receivables	0.78	0.4	0.62	0.7	-0.55	-0.62	0.64	0.58	0.7	0.59	0.58		-0.06	0.71	0.51	0.72	0.66	0.61	0.55	0.72	0.38	-0.09	0.57	0.73	-0.04	0.59
Common Stock Total Equity	-0.03	0.46	0.08	-0.12	0.15	-0.09	0.09	-0.09	-0.15	-0.29	-0.09	-0.06		0.23	0.21	0.12	0.06	0.13	-0.01	-0.03	-0.38	0.99	-0.11	-0.14	0.41	0.07
Common Stock Shares Outstanding	0.87	0.51	0.87	0.67	-0.61	-0.88	0.93	0.65	0.85	0.64	0.65	0.71	0.23		0.76	0.94	0.87	0.87	0.72	0.79	0.46	0.18	0.76	0.86	-0.06	0.72
Non Current Liabilities Total	0.62	0.78	0.84	0.36	-0.37	-0.89	0.75	0.48	0.71	0.39	0.48	0.51	0.21	0.76		0.83	0.85	0.92	0.79	0.66	0.16	0.17	0.74	0.83	-0.35	0.89
Inventory	0.8	0.62	0.87	0.55	-0.48	-0.87	0.95	0.54	0.82	0.58	0.54	0.72	0.12	0.94	0.83		0.84	0.89	0.73	0.72	0.37	0.06	0.74	0.9	-0.23	0.75
Other Stockholder Equity	0.81	0.46	0.96	0.64	-0.69	-0.99	0.79	0.76	0.81	0.61	0.76	0.66	0.06	0.87	0.85	0.84		0.96	0.94	0.9	0.44	0.01	0.96	0.84	-0.2	0.88
Total Liab	0.74	0.6	0.99	0.51	-0.55	-0.98	0.87	0.64	0.78	0.53	0.64	0.61	0.13	0.87	0.92	0.89	0.96		0.91	0.82	0.37	0.08	0.91	0.84	-0.24	0.85
Property Plant And Equipment Gross	0.65	0.41	0.92	0.49	-0.58	-0.93	0.67	0.66	0.65	0.43	0.66	0.55	-0.01	0.72	0.79	0.73	0.94	0.91		0.81	0.27	-0.07	0.96	0.71	-0.25	0.85
Total Current Assets	0.93	0.35	0.84	0.89	-0.92	-0.83	0.69	0.96	0.81	0.8	0.96	0.72	-0.03	0.79	0.66	0.72	0.9	0.82	0.81		0.67	-0.07	0.87	0.76	-0.15	0.73
Intangible Assets	0.72	-0.09	0.44	0.78	-0.81	-0.35	0.49	0.76	0.67	0.9	0.76	0.38	-0.38	0.46	0.16	0.37	0.44	0.37	0.27	0.67		-0.39	0.47	0.5	-0.11	0.15
Common Stock	-0.08	0.42	0.03	-0.16	0.19	-0.04	0.04	-0.12	-0.18	-0.31	-0.12	-0.09	0.99	0.18	0.17	0.06	0.01	0.08	-0.07	-0.07	-0.39		-0.16	-0.17	0.46	0.03
Other Current Liab	0.74	0.32	0.94	0.6	-0.7	-0.94	0.71	0.76	0.71	0.57	0.76	0.57	-0.11	0.76	0.74	0.74	0.96	0.91	0.96	0.87	0.47	-0.16		0.74	-0.26	0.79
Property Plant And Equipment Net	0.83	0.53	0.81	0.64	-0.57	-0.85	0.87	0.62	0.95	0.7	0.62	0.73	-0.14	0.86	0.83	0.9	0.84	0.84	0.71	0.76	0.5	-0.17	0.74		-0.33	0.84
Current Deferred Revenue	-0.16	-0.29	-0.19	-0.06	0.09	0.24	-0.21	-0.12	-0.16	-0.11	-0.12	-0.04	0.41	-0.06	-0.35	-0.23	-0.2	-0.24	-0.25	-0.15	-0.11	0.46	-0.26	-0.33		-0.35
Other Current Assets	0.66	0.57	0.8	0.48	-0.49	-0.89	0.65	0.57	0.73	0.4	0.57	0.59	0.07	0.72	0.89	0.75	0.88	0.85	0.85	0.73	0.15	0.03	0.79	0.84	-0.35

Click cells to compare fundamentals

Chromadex Corp Account Relationship Matchups

Chromadex Corp balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	40.2M	38.4M	57.8M	54.1M	55.0M	28.4M
Short Long Term Debt Total	1.7M	1.6M	4.7M	4.3M	3.3M	1.7M
Total Current Liabilities	15.1M	16.5M	17.6M	17.9M	20.6M	21.7M
Total Stockholder Equity	20.4M	16.4M	31.7M	28.7M	28.5M	15.9M
Net Debt	(17.1M)	(14.9M)	(23.3M)	(16.0M)	(23.9M)	(22.7M)
Retained Earnings	(121.9M)	(141.8M)	(169.0M)	(185.5M)	(190.5M)	(180.9M)
Accounts Payable	9.6M	9.4M	10.4M	9.7M	10.2M	5.6M
Cash	18.8M	16.5M	28.0M	20.2M	27.3M	28.7M
Non Current Assets Total	6.7M	6.1M	8.9M	7.5M	5.4M	4.3M
Non Currrent Assets Other	762K	625K	723K	497K	383K	354.2K
Cash And Short Term Investments	18.8M	16.5M	28.0M	20.2M	27.3M	28.7M
Net Receivables	2.2M	2.7M	5.2M	8.5M	5.2M	3.2M
Common Stock Total Equity	60K	62K	68K	74K	85.1K	69.4K
Common Stock Shares Outstanding	57.1M	61.1M	67.2M	69.7M	75.0M	43.1M
Liabilities And Stockholders Equity	40.2M	38.4M	57.8M	54.1M	55.0M	28.4M
Non Current Liabilities Total	4.7M	5.5M	8.5M	7.5M	5.9M	6.2M
Inventory	11.5M	11.7M	13.6M	14.7M	14.5M	7.4M
Other Stockholder Equity	142.3M	158.2M	200.6M	214.1M	218.8M	229.8M
Total Liab	19.8M	21.9M	26.1M	25.4M	26.5M	27.8M
Property Plant And Equipment Gross	4.7M	4.4M	7.4M	6.3M	9.9M	10.4M
Total Current Assets	33.5M	32.2M	48.9M	46.6M	49.5M	52.0M
Accumulated Other Comprehensive Income	(2.1M)	0.0	(3K)	(2K)	(4K)	(4.2K)
Intangible Assets	1.3M	1.1M	857K	671K	510K	694.8K
Common Stock	60K	62K	68K	74K	75K	70.5K
Other Current Liab	4.4M	5.5M	5.4M	5.9M	8.1M	8.5M
Property Plant And Equipment Net	4.7M	4.4M	7.4M	6.3M	4.5M	3.2M
Current Deferred Revenue	169K	278K	161K	157K	195K	263.8K
Other Current Assets	996K	1.3M	3.7M	3.0M	2.5M	2.6M
Short Term Debt	853K	1.2M	1.1M	1.4M	1.4M	1.5M
Other Liab	3.9M	4.4M	4.3M	4.0M	4.5M	4.8M
Net Tangible Assets	19.1M	16.4M	30.9M	28.0M	32.2M	18.4M
Other Assets	762K	625K	723K	497K	571.6K	600.1K
Retained Earnings Total Equity	(121.9M)	(141.8M)	(169.0M)	(185.5M)	(166.9M)	(158.6M)
Property Plant Equipment	4.7M	3.2M	7.4M	6.3M	7.3M	7.6M
Capital Surpluse	142.3M	158.2M	200.6M	214.1M	246.2M	258.5M
Capital Lease Obligations	1.7M	1.6M	4.7M	4.3M	3.3M	1.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:

How To Invest In Chromadex

Details

Is Chromadex Stock a good investment?

Details

What is Chromadex Corp's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

0.02

Revenue Per Share

1.215

Quarterly Revenue Growth

0.312

Return On Assets

0.0051

Return On Equity

0.0482

The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chromadex Historical Balance Sheet

Chromadex Corp Inventory

7.36 Million

About Chromadex Balance Sheet Analysis

Chromadex Corp Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Capital Lease Obligations

Chromadex Corp balance sheet Correlations

Chromadex Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chromadex Corp balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Total Current Liabilities
Common Stock	+ 0.99	Common Stock Total Equity
Other Stockholder Equity	+ 0.96	Total Current Liabilities
Total Current Assets	+ 0.96	Cash
Total Current Assets	+ 0.96	Cash And Short Term Investments

Other Stockholder Equity	- 0.99	Retained Earnings
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Total Liab	- 0.98	Retained Earnings
Retained Earnings	- 0.96	Total Current Liabilities
Net Debt	- 0.95	Total Stockholder Equity